EuBiologics Co. Ltd.
206650.KQ
| Exchange: | KQ |
| Currency | Korean Won |
| Open Figi: | BBG00F90XZ93 |
| Fiscal Year End: | September |
| Sector: | Healthcare |
| Industry: | Drug Manufacturers - Specialty & Generic |
| Description: | Eu Biologics Co., Ltd., a biopharmaceutical company, provides vaccines for epidemics in South Korea. It offers Euvichol Plus, an oral cholera prevention vaccine; and r CRM197, a diphtheria toxoid vaccine. The company also provides Ec ML, a vaccine for cell membrane, as well as offers COVID-19 diagnostic kits. In addition, it offers CMO services comprising of drug product production, cell bank production, and drug substance production. Further, the company provides CRMO services, including cell line development, GMP production, validation, and the regulatory support; and operates facilities that manufacture protein-based therapeutics and antibodies. Additionally, it offers contract testing services that include lot release, stability, raw material, and method validation testing services. Eu Biologics Co., Ltd. was founded in 2010 and is headquartered in Seoul, South Korea. |
| Address: | Seongdo Building, Seoul, South Korea |
| Website: | https://www.eubiologics.com |
| Updated On: | 2024-11-09 |
Highlights
| Market Capitalization: | 598707339264 |
| Market Capitalization Mln: | 598707.33 |
| EBITDA: | 16867054592 |
| Wall Street Target Price: | 14000 |
| Most Recent Quarter: | 2023-12-31 |
| Profit Margin: | -0.20 |
| Operating Margin TTM: | 0.35 |
| Return On Assets TTM: | 0.03 |
| Return On Equity TTM: | -0.13 |
| Revenue TTM: | 69365661696 |
| Revenue Per Share TTM: | 1903.15 |
| Quarterly Revenue Growth YOY: | 0.54 |
Valuation
| Price Sales TTM: | 8.63 |
| Price Book MRQ: | 5.56 |
| Enterprise Value: | 596973631680 |
| Enterprise Value Revenue: | 8.60 |
| Enterprise Value Ebitda: | 58.03 |
Shares
| Shares Outstanding: | 36484300 |
| Shares Float: | 29578701 |
| Percent Insiders: | 21.44 |
| Percent Institutions: | 9.48 |
Technicals
| Beta: | 1.24 |
| 52 Week High: | 18800 |
| 52 Week Low: | 8740 |
| 50 Day MA: | 12357.8 |
| 200 Day MA: | 12114.65 |
Earnings
| Report Date: | 2024-06-30 |
| Date: | 2024-06-30 |
| Eps Actual: | -43.58 |
| Report Date: | 2024-03-31 |
| Date: | 2024-03-31 |
| Eps Actual: | -99.16 |
| Report Date: | 2023-12-31 |
| Date: | 2023-12-31 |
| Eps Actual: | -348.62 |
| Report Date: | 2023-09-30 |
| Date: | 2023-09-30 |
| Eps Actual: | -85.10 |
| Report Date: | 2023-06-30 |
| Date: | 2023-06-30 |
| Eps Actual: | 55.83 |
| Report Date: | 2023-03-31 |
| Date: | 2023-03-31 |
| Eps Actual: | -2.90 |
| Report Date: | 2022-12-31 |
| Date: | 2022-12-31 |
| Eps Actual: | -87.56 |
| Report Date: | 2022-09-30 |
| Date: | 2022-09-30 |
| Eps Actual: | 6.84 |
| Report Date: | 2022-06-30 |
| Date: | 2022-06-30 |
| Eps Actual: | 47.33 |
| Report Date: | 2022-03-31 |
| Date: | 2022-03-31 |
| Eps Actual: | 3.26 |
| Report Date: | 2021-12-31 |
| Date: | 2021-12-31 |
| Eps Actual: | -1.94 |
| Report Date: | 2021-09-30 |
| Date: | 2021-09-30 |
| Eps Actual: | 57.25 |
| Report Date: | 2021-06-30 |
| Date: | 2021-06-30 |
| Eps Actual: | -756.99 |
| Report Date: | 2021-03-31 |
| Date: | 2021-03-31 |
| Eps Actual: | -85.73 |
| Report Date: | 2021-02-09 |
| Date: | 2020-12-31 |
| Before After Market: | After Market |
| Eps Actual: | 187.63 |
| Report Date: | 2020-11-13 |
| Date: | 2020-09-30 |
| Before After Market: | After Market |
| Eps Actual: | -2131.24 |
| Report Date: | 2020-08-14 |
| Date: | 2020-06-30 |
| Before After Market: | After Market |
| Eps Actual: | -409.5 |
| Report Date: | 2020-05-14 |
| Date: | 2020-03-31 |
| Before After Market: | After Market |
| Eps Actual: | 249.55 |
| Report Date: | 2020-02-06 |
| Date: | 2019-12-31 |
| Before After Market: | After Market |
| Eps Actual: | -136.09 |
| Report Date: | 2019-11-06 |
| Date: | 2019-09-30 |
| Before After Market: | After Market |
| Eps Actual: | 319.89 |
| Report Date: | 2019-08-14 |
| Date: | 2019-06-30 |
| Before After Market: | After Market |
| Eps Actual: | -169.58 |
| Report Date: | 2019-05-08 |
| Date: | 2019-03-31 |
| Before After Market: | Before Market |
| Eps Actual: | -37.58 |
| Report Date: | 2019-01-31 |
| Date: | 2018-12-31 |
| Before After Market: | Before Market |
| Eps Actual: | 32.76 |
| Report Date: | 2018-11-13 |
| Date: | 2018-09-30 |
| Before After Market: | After Market |
| Eps Actual: | -89.61 |
| Report Date: | 2018-08-14 |
| Date: | 2018-06-30 |
| Before After Market: | After Market |
| Eps Actual: | 78 |
| Report Date: | 2018-05-03 |
| Date: | 2018-03-31 |
| Before After Market: | After Market |
| Eps Actual: | 81.12 |
| Report Date: | 2018-02-12 |
| Date: | 2017-12-31 |
| Before After Market: | After Market |
| Eps Actual: | -41.38 |
| Report Date: | 2017-11-17 |
| Date: | 2017-09-30 |
| Before After Market: | After Market |
| Eps Actual: | -47.19 |
| Report Date: | 2017-08-14 |
| Date: | 2017-06-30 |
| Before After Market: | After Market |
| Eps Actual: | -56.47 |
| Report Date: | 2017-05-12 |
| Date: | 2017-03-31 |
| Before After Market: | After Market |
| Eps Actual: | -35.71 |
| Date: | 2024-06-30 |
| Eps Actual: | -491.38 |
| Date: | 2023-09-30 |
| Eps Actual: | -119.74 |
| Date: | 2022-09-30 |
| Eps Actual: | 55.50 |
| Date: | 2021-09-30 |
| Eps Actual: | -597.83 |
| Date: | 2020-09-30 |
| Eps Actual: | -2427.28 |
| Date: | 2019-09-30 |
| Eps Actual: | 145.4 |
| Date: | 2018-09-30 |
| Eps Actual: | 28.12 |
| Date: | 2017-09-30 |
| Eps Actual: | -139.38 |